Top 10 companies in diabetes care devices market

diabetes care devices market

Diabetes mellitus (diabetes) is a highly prevalent chronic metabolic disorder that interferes with the body’s ability to produce or effectively use insulin. Insulin is a hormone that regulates blood sugar. Hyper glycaemia, or raised blood sugar, is a common effect of uncontrolled diabetes and over time leads to serious damage to many of the body’s systems, especially the nerves and blood vessels. Each year more and more people live with this condition, which can result in life-changing complications.

According to WHO, in 2015, an estimated 1.6 million deaths were directly caused by diabetes. In addition, to the 415 million adults who are estimated to have diabetes globally in 2015, there are 318 million adults with impaired glucose tolerance, which puts them at high risk of developing the chronic disease in the future.

According to latest publication from Meticulous Research, global diabetes care devices market is expected to grow at a CAGR of 5.3% during the forecast period to reach USD 26,710.3 million by 2022.

Here are the leading 10 companies operating in this market-

Novo Nordisk A/S

Novo Nordisk A/S was founded in 1923 with its headquarter in Bagsvaerd, Denmark. The company operates in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. The company operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles.

The company sales & markets its products & services in more than 170 countries with strong geographical presence across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Ypsomed AG

ypsomedYpsomed AG was founded in 1984 and is headquartered in Switzerland. The company operates through three business segments namely Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others segments. The Ypsomed Diabetes Care segment sells and trades insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, with its subsidiaries namely Ypsomed Distribution AG, DiaExpert GmbH, Florian Müller GmbH, Ypsomed, and Ypsotec Ag.

Abbott Laboratories

abbottAbbott Laboratories (Abbott) founded in 1888 and is headquartered at Illinois, U.S. The company operates into the manufacturing & sales of health care products worldwide. The company operates through four business segments i.e. nutritionals, pharmaceuticals, diagnostics, vascular, and others. The diabetes care products are offered through its diagnostics segment. The company offers blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, with more than 28 subsidiaries worldwide including Abbott Diabetes Care, Inc., and Abbott Molecular Inc.

Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care Holdings AG is established in 2016 through the acquisition of Bayer Diabetes Care by Panasonic Healthcare Holdings. Headquartered in Switzerland, the company operates as a subsidiary of Panasonic Healthcare Holdings and is engaged in providing blood glucose monitoring systems, lancing devices, and diabetes management software.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Hoffmann-La Roche Ltd.

Hoffmann-La Roche Ltd. founded in 1896 is headquartered in Basel, Switzerland. Hoffmann-La Roche Ltd. operates through two divisions i.e. Pharmaceuticals and Diagnostics. The pharmaceuticals division comprises the two business segments Roche pharmaceuticals and chugai. The diagnostics division consists of the four business areas i.e. diabetes care, molecular diagnostics, professional diagnostics and tissue diagnostics. The company’s diabetes care division provides home blood glucose monitoring products and point-of-care testing devices for in-vitro diagnosis.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Johnson & Johnson

johnson & johnsonJohnson & Johnson was founded in 1887 and is headquartered in New Jersey; U.S. Johnson & Johnson is engaged in developing and marketing of healthcare products globally. Johnson & Johnson operates in three business segments: consumer, pharmaceuticals, and medical devices and diagnostics. The company offers self-monitoring blood glucose meters and insulin delivery devices through its medical devices and diagnostics segment.

The company has strong geographic presence across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa and markets and sales its products in these geographies through more than 230 operating companies located in 60 countries. Johnson & Johnson operates into the diabetes Care market specifically through LifeScan, Inc., Animas Corporation, and Calibra Medical, Inc.

Medtronic PLC

Medtronic PLCMedtronic was founded in 1949 and is headquartered in Dublin, Ireland. The company operates in four business segments i.e. Cardiac And Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Diabetes Group consists of three divisions (Intensive Insulin Management, Non-Intensive Diabetes Therapies, and Diabetes Services & Solutions) that develop, manufacture, and market advanced, integrated diabetes management solutions including insulin pump therapy, continuous glucose monitoring (CGM) systems, and therapy management software.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The company operates through more than 30 subsidiaries including Covidien Ltd., Medtronic Limited, and Medtronic CoreValve LLC.

Becton, Dickinson and Company

1. Becton, Dickinson and Company (U.S.)Becton, Dickinson and Company was founded in 1897 and is headquartered in New Jersey, U.S. The company operates in two business segments i.e. BD Medical and BD Life Sciences. BD medical operates in four segments i.e. Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, and Pharmaceutical Systems. The diabetes care segment offers syringes, pen needles, used in the treatment of diabetes.

The company markets & sales its products internationally through independent distribution channels across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa, and has more than 30 subsidiaries including GeneOhm Sciences Canada Inc., Becton Dickinson Medical Products Pte. Ltd., Becton Dickinson GmbH, and Becton Dickinson France SAS.

Terumo Corporation

Terumo Corporation founded in 1921, is headquartered in Tokyo, Japan. The company manufactures and sells medical devices and pharmaceuticals worldwide. It also provides diabetes management devices, measuring device systems such as blood glucose and blood pressure monitors; thermometers; pulse oximeters; and walking intensity and body composition monitors.

The company has its geographical presence in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Sanofi

Sanofi was founded in 1973 and is headquartered in Paris, France. The company operates in two segments, Pharmaceuticals and Vaccines. The pharmaceutical segment offers diabetic devices such as SoloSTAR, ClikSTAR, JuniorSTAR, MyStar Extra meter, MyStar Connect to treat diabetes. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines.

The company manufactures and sells its products in more than 170 countries across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

To download a sample Report on Diabetes Care Devices Market, please visit the below link:

https://www.meticulousresearch.com/product/diabetes-care-devices-market-2022/

Leave a Reply

Your email address will not be published. Required fields are marked *